Статья

Humoral Immunity to Sars-CoV-2 Among The Population of Murmansk Region Amid COVID-19 Epidemic

A. Popova, E. Ezhlova, A. Melnikova, L. Lukicheva, N. Nikitina, L. Lyalina, V. Smirnov, N. Koltsov, M. Ermakova, A. Kubashev, V. Kuznetsova, T. Denisova, N. Gurina, I. Ziborov, I. Gryazova, N. Pankova, P. Konoshkin, N. Mikheeva, A. Sharova, A. Totolian,
2021

Purpose of the study. Determination of the level and structure of population immunity to SARS-CoV-2 among the population of the Murmansk region against the background of the incidence of COVID-19. Materials and methods. The study was carried out according to a unified method for determining the seroprevalence of the population, developed by Rospotrebnadzor with the participation of the St. Petersburg Pasteur Institute. A total of 3117 volunteers were examined, distributed into 7 age groups. The content of antibodies to SARS-CoV-2 was determined by ELISA using a set of reagents for analyzing human serum or plasma for the presence of specific immunoglobulins of class G to the nucleocapsid of the SARS-CoV-2 virus produced by the FBUN GNCPMiB Rospotrebnadzor (Obolensk) in accordance with the instructions for application. Results. The level of population immunity in the Murmansk region as a whole was 31,2%. The highest seroprevalence was found among children aged 1–6 and 7–13 years (35.6% and 44,1%, respectively), the lowest among the elderly population aged 60–69, as well as 70 and more years (20,4% and 20,9%, respectively). In the cities of the Murmansk region. the herd level of immunity varied from 19,6% (Kola city) to 46,1% (Kandalaksha city). It was not possible to find a reliable relationship between the incidence of the population of the cities of the Murmansk region and seroprevalence. The highest level of seroprevalence was noted among office workers (38,0%), the lowest among transport workers (19,5%). In the presence of contacts with patients with COVID-19, seropositivity increased 1,4 times compared to the average population value. The level of specific humoral immunity in convalescents after COVID-19 is 64,1%, which is 2,2 times higher than the average for half-day. The proportion of asymptomatic forms among seroprevalence volunteers was 89%.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-01-01

Метаданные

Об авторах
  • A. Popova
    Federal Service for Supervision of Consumer Rights Protection and Human Welfare
  • E. Ezhlova
    Federal Service for Supervision of Consumer Rights Protection and Human Welfare
  • A. Melnikova
    Federal Service for Supervision of Consumer Rights Protection and Human Welfare
  • L. Lukicheva
    Rospotrebnadzor Department in the Murmansk Region
  • N. Nikitina
    Center for Hygiene and Epidemiology in the Murmansk Region
  • L. Lyalina
    Saint-Petersburg Pasteur Institute
  • V. Smirnov
    Saint-Petersburg Pasteur Institute
  • N. Koltsov
    Rospotrebnadzor Department in the Murmansk Region
  • M. Ermakova
    Rospotrebnadzor Department in the Murmansk Region
  • A. Kubashev
    Center for Hygiene and Epidemiology in the Murmansk Region
  • V. Kuznetsova
    Center for Hygiene and Epidemiology in the Murmansk Region
  • T. Denisova
    Center for Hygiene and Epidemiology in the Murmansk Region
  • N. Gurina
    Center for Hygiene and Epidemiology in the Murmansk Region
  • I. Ziborov
    Center for Hygiene and Epidemiology in the Murmansk Region
  • I. Gryazova
    Center for Hygiene and Epidemiology in the Murmansk Region
  • N. Pankova
    Center for Hygiene and Epidemiology in the Murmansk Region
  • P. Konoshkin
    Center for Hygiene and Epidemiology in the Murmansk Region
  • N. Mikheeva
    Center for Hygiene and Epidemiology in the Murmansk Region
  • A. Sharova
    Saint-Petersburg Pasteur Institute
  • A. Totolian
    Saint-Petersburg Pasteur Institute
Название журнала
  • HIV Infection and Immunosuppressive Disorders
Том
  • 13
Выпуск
  • 1
Страницы
  • 17-27
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus